封面
市場調查報告書
商品編碼
1477175

伴隨診斷市場,按產品類型、應用、技術、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Companion Diagnostics Market, By Product Type, By Application, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年伴隨診斷市場規模為 6978.12 億美元,2024 年至 2032 年複合年成長率為 12.2%。

伴隨診斷市場-市場動態

個人化藥物的重要性與日俱增

人們越來越意識到個人化藥物,因為它們允許根據個別患者的特定基因組成或特徵進行客製化治療。伴隨診斷有助於識別生物標記或遺傳變異,從而預測患者對特定治療的反應。這使得醫生能夠根據每個患者獨特的基因譜為他們開出最合適的藥物。這些測試使醫療保健提供者能夠做出明智的臨床決策並避免不必要事件的風險。因此,個人化藥物和伴隨診斷的重要性日益增強,代表著醫療保健領域向更精確、更有效和以患者為中心的治療方法的範式轉變。

伴隨診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 12.2% 左右的複合年成長率成長

根據產品類型細分,檢測、試劑盒和試劑細分市場佔據主導地位

根據最終用戶細分,製藥和生物技術領域在市場中佔據主導地位,並可能在預測期內保持其主導地位

按地區分類,北美是 2023 年的主要收入來源

伴隨診斷市場細分分析:

全球伴隨診斷市場根據產品類型、技術、應用、最終用戶和地區進行細分。

根據產品類型,市場分為兩類:檢測、試劑盒和試劑以及軟體和服務。由於產品種類繁多以及檢測方法和醫療保健領域的使用不斷增加,檢測方法、試劑盒和試劑領域佔據了市場主導地位。

根據最終用戶,市場分為三類:製藥和生物技術公司、臨床研究組織和參考實驗室。製藥和生物技術領域在市場上佔據主導地位,並可能在預測期內保持其主導地位。伴隨診斷的日益普及是由於藥物開發在醫療保健行業中的重要性日益增加。

伴隨診斷市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

伴隨診斷市場由北美主導。眾多著名的伴隨診斷供應商和開放的臨床研究設施的存在、技術先進的設備和工具的便捷獲取以及美國和加拿大顯著變化的醫療服務基礎設施都是促進北方朋友診斷市場成長的因素。此外,由於亞太地區人口基數高、伴隨診斷意識不斷增強、醫療基礎設施改善以及對尖端療法的需求不斷成長,該地區為市場參與者提供了利潤豐厚的機會。例如,2023 年 11 月,FDA 批准 FoundationOne CDx 用作伴隨診斷,以識別有資格接受治療的晚期荷爾蒙受體陽性晚期乳癌患者。

伴隨診斷市場-競爭格局:

擁有強大國際影響力和分銷網路的公司在接觸全球醫療保健提供者和患者方面具有優勢。伴隨診斷的主要市場參與者包括雅培分子公司、賽默飛世爾科技公司、Dako Inc.、Qiagen Ltd等,在伴隨診斷開發方面擁有獨特的技術能力和專業知識。例如,Thermo Fisher Scientific 以其在分子診斷方面的專業知識而聞名,並在該領域提供廣泛的產品。而雅培分子公司則擁有強大的分子檢測產品組合。在伴隨診斷市場中,遵守監管要求(例如 FDA 批准和歐洲 CE 標誌)至關重要。擁有成功監管批准和遵守品質標準記錄的公司可能擁有更強大的地位。

最近的發展:

2023年11月,美國分子洞察公司Foundation Medicine Inc.宣布,其FoundationOneCDx已獲得美國食品藥物管理局(FDA)的批准,可用作阿斯利康Truqap的伴隨診斷。

報告範圍

本報告的範圍涵蓋了主要細分市場,其中包括:

全球伴隨診斷市場主要參與者 - 詳細的競爭見解

奧雅納實驗室

羅氏分子系統公司

達科公司

凱傑有限公司

生物梅里埃公司

文塔納醫療系統公司

雅培分子公司

無數遺傳學公司

Biogenex 實驗室有限公司

賽默飛世爾科技公司

徠卡生物系統努斯洛赫有限公司

其他

全球伴隨診斷市場,按產品類型分類 - 市場分析,2019 - 2032

  • 檢測、試劑盒和試劑
  • 軟體與服務

全球伴隨診斷市場,按應用分類 - 市場分析,2019 - 2032

  • 腫瘤學
  • 心血管疾病
  • 傳染性疾病
  • 神經系統疾病

全球伴隨診斷市場(按技術-市場分析),2019 - 2032 年

  • 免疫組織化學
  • 分子診斷
  • 原位雜合技術
  • CISH

全球伴隨診斷市場(按最終用戶分類)2019 - 2032 年市場分析

  • 製藥和生物技術公司
  • 臨床研究組織
  • 參考實驗室

全球伴隨診斷市場(按地區分類)市場分析,2019 - 2032 年

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 英國
  • 俄羅斯
  • 荷蘭
  • 瑞典
  • 波蘭
  • 歐洲其他地區
  • 亞太地區
  • 印度
  • 中國
  • 韓國
  • 日本
  • 澳洲
  • 泰國
  • 印尼
  • 菲律賓
  • 亞太地區其他地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥倫比亞
  • 拉丁美洲其他地區
  • 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 土耳其
  • 阿爾及利亞
  • 埃及
  • MEA 的其餘部分

目錄

第 1 章:伴隨診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按產品類型分類的伴隨診斷市場片段
    • 按應用分類的伴隨診斷市場片段
    • 按技術分類的伴隨診斷市場片段
    • 最終用戶的伴隨診斷市場片段
    • 按國家/地區分類的伴隨診斷市場片段
    • 按地區分類的伴隨診斷市場片段
  • 競爭洞察

第 3 章:伴隨診斷主要市場趨勢

  • 伴隨診斷市場促進因素
    • 市場促進因素的影響分析
  • 伴隨診斷市場限制
    • 市場限制影響分析
  • 伴隨診斷市場機會
  • 伴隨診斷市場未來趨勢

第 4 章:伴隨診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:伴隨診斷市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:伴隨診斷市場格局

  • 2023 年伴隨診斷市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:伴隨診斷市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 檢測、試劑盒和試劑
    • 軟體與服務

第 8 章:伴隨診斷市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
    • 心血管疾病
    • 傳染性疾病
    • 神經系統疾病

第 9 章:伴隨診斷市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 免疫組織化學
    • 分子診斷
    • 原位雜合技術
    • CISH

第 10 章:伴隨診斷市場 - 按最終用戶

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 製藥和生物技術公司
    • 臨床研究組織
    • 參考實驗室

第 11 章:伴隨診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • Companion Diagnostics 北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按產品類型)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按技術)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲 Companion Diagnostics 主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按產品類型)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模與預測(按技術)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • Companion Diagnostics 亞太地區主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(依產品類型)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模與預測(按技術)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲 Companion Diagnostics 主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按產品類型)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模與預測(按技術)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • Companion Diagnostics 中東和非洲主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按產品類型)
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模及預測(按技術)
    • 中東和非洲市場規模及預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章:主要供應商分析 - 伴隨診斷產業

  • 競爭儀表板
  • 公司簡介
    • ARUP Laboratories
    • Roche Molecular Systems Inc.
    • Dako Inc.
    • Qiagen Ltd.
    • bioMerieux Inc.
    • Ventana Medical Systems Inc.
    • Abbott Molecular Inc.
    • Myriad Genetics Inc.
    • Biogenex Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Leica Biosystems Nussloch GmbH
    • Others

第 13 章:360 度分析師視角

第 14 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2573

REPORT HIGHLIGHT

Companion Diagnostics Market size was valued at USD 6,978.12 Million in 2023, expanding at a CAGR of 12.2% from 2024 to 2032.

A companion diagnostic is a medical instrument, frequently an in vitro diagnostic (IVD), that offers data necessary for the safe and efficient administration of a related medication or biological product. It identifies patients who are likely to be at increased risk for serious side effects due to the treatment with a particular therapeutic product. In addition, there is an increasing prevalence of carcinogenic diseases which increases the need for effective genomic testing, leading to global demand for companion diagnostics. However, high capital investment is necessary for the discovery, development and validation of biomarkers, which is hindering the growth of the market. Furthermore, companion diagnostics are increasingly used in drug development by healthcare providers which caused substantial growth in the market.

Companion Diagnostics Market- Market Dynamics

Growing Significance of Personalized Medicines

There is a growing awareness of personalized medicines as they allow for treatments that are tailored to the specific genetic makeup or characteristics of an individual patient. Companion diagnostics help identify biomarkers or genetic variations that can predict how a patient will respond to a particular treatment. This enables physicians to prescribe the most suitable medication for each patient based on their unique genetic profile. These tests empower healthcare providers to make informed clinical decisions and avoid the risk of unnecessary events. Therefore the growing significance of personalized medicines and companion diagnostics represents a paradigm shift in healthcare towards more precise, effective, and patient-centered approaches to treatment.

Companion Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.2% over the forecast period (2024-2032)

Based on product type segmentation, the assay, kits & reagents segments dominated the market

Based on end user segmentation, the pharma and biotech segment dominates the market and is likely to maintain its dominance during the forecast period

Based on region, North America was the leading revenue generator in 2023

Companion Diagnostics Market- Segmentation Analysis:

The Global Companion Diagnostics Market is segmented based on Product Type, Technology, Application, End User, and Region.

The market is divided into two categories based on product type: assay, kits & reagents and software & services. The assay, kits & reagents segments dominated the market due to the availability of a wide variety of products and the growing usage of assays and in the healthcare sector.

The market is divided into three categories based on end users: pharma & biotech companies, clinical research organizations and reference laboratories. The pharma and biotech segment dominates the market and is likely to maintain its dominance during the forecast period. The rising adoption of companion diagnostics is due to the increasing significance of drug development in the healthcare industry.

Companion Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

The market for companion diagnostics is dominated by North America. The presence of numerous prominent companion diagnostics vendors and open clinical research facilities, the easy accessibility of technologically advanced devices and tools, and the significantly changed medical services infrastructure in the US and Canada are all factors contributing to the growth of the friend diagnostics market in North America. Furthermore, Asia-Pacific offers lucrative opportunities for market participants because of the region's high population base, growing awareness of companion diagnostics, improved medical care infrastructure, and growing demand for cutting-edge therapies. For instance, in November 2023, the FDA approved the FoundationOne CDx for use as a companion diagnostic to identify patients with advanced hormone receptor-positive, advanced breast cancer who are eligible for treatment.

Companion Diagnostics Market- Competitive Landscape:

Companies with a strong international presence and distribution network have an advantage in reaching healthcare providers and patients globally. The key market players in companion diagnostics include Abbott Molecular Inc., Thermo Fisher Scientific Inc., Dako Inc., Qiagen Ltd, etc. have distinct technological capabilities and expertise in companion diagnostics development. For instance, Thermo Fisher Scientific is known for its expertise in molecular diagnostics and has a wide range of offerings in this area. while Abbott Molecular Inc. has a strong portfolio of molecular assays. Compliance with regulatory requirements, such as FDA approvals and CE marking in Europe, is crucial in the companion diagnostics market. Companies with a track record of successful regulatory approvals and adherence to quality standards may have a stronger position.

Recent Developments:

In November 2023, Foundation Medicine Inc. an American molecular insight company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOneCDx to be used as a companion diagnostic for AstraZeneca's Truqap.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPANION DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

ARUP Laboratories

Roche Molecular Systems Inc.

Dako Inc.

Qiagen Ltd.

bioMerieux Inc.

Ventana Medical Systems Inc.

Abbott Molecular Inc.

Myriad Genetics Inc.

Biogenex Laboratories, Inc.

Thermo Fisher Scientific Inc.

Leica Biosystems Nussloch GmbH

Others

GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Assay, Kits & Reagents
  • Software & Services

GLOBAL COMPANION DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurological Diseases

GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Immunohistochemistry
  • Molecular Diagnostics
  • In-situ Hybridization
  • FISH
  • CISH

GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharma and Biotech Companies
  • Clinical Research Organizations
  • Reference Laboratories

GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Companion Diagnostics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Companion Diagnostics Market Snippet by Product Type
    • 2.1.2.Companion Diagnostics Market Snippet by Application
    • 2.1.3.Companion Diagnostics Market Snippet by Technology
    • 2.1.4.Companion Diagnostics Market Snippet by End User
    • 2.1.5.Companion Diagnostics Market Snippet by Country
    • 2.1.6.Companion Diagnostics Market Snippet by Region
  • 2.2.Competitive Insights

3.Companion Diagnostics Key Market Trends

  • 3.1.Companion Diagnostics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Companion Diagnostics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Companion Diagnostics Market Opportunities
  • 3.4.Companion Diagnostics Market Future Trends

4.Companion Diagnostics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Companion Diagnostics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Companion Diagnostics Market Landscape

  • 6.1.Companion Diagnostics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Companion Diagnostics Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Assay, Kits & Reagents
    • 7.1.3.Software & Services

8.Companion Diagnostics Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Cardiovascular Diseases
    • 8.1.4.Infectious Diseases
    • 8.1.5.Neurological Diseases

9.Companion Diagnostics Market - By Technology

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 9.1.2.Immunohistochemistry
    • 9.1.3.Molecular Diagnostics
    • 9.1.4.In-situ Hybridization
    • 9.1.5.FISH
    • 9.1.6.CISH

10.Companion Diagnostics Market - By End User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Pharma and Biotech Companies
    • 10.1.3.Clinical Research Organizations
    • 10.1.4.Reference Laboratories

11.Companion Diagnostics Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Companion Diagnostics Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Companion Diagnostics Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Companion Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Companion Diagnostics Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Companion Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Companion Diagnostics Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.ARUP Laboratories
    • 12.2.2.Roche Molecular Systems Inc.
    • 12.2.3.Dako Inc.
    • 12.2.4.Qiagen Ltd.
    • 12.2.5.bioMerieux Inc.
    • 12.2.6.Ventana Medical Systems Inc.
    • 12.2.7.Abbott Molecular Inc.
    • 12.2.8.Myriad Genetics Inc.
    • 12.2.9.Biogenex Laboratories, Inc.
    • 12.2.10.Thermo Fisher Scientific Inc.
    • 12.2.11.Leica Biosystems Nussloch GmbH
    • 12.2.12.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Companion Diagnostics Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Companion Diagnostics Market, by Product Type 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Companion Diagnostics Market, by Application 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Companion Diagnostics Market, by Technology 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Companion Diagnostics Market, by End User 2019-2032 (USD Million)
  • TABLE Companion Diagnostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Companion Diagnostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Companion Diagnostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Companion Diagnostics Market, by End User, 2019-2032 (USD Million)